Pfizer (NYSE:PFE) Price Target Cut to $29.00 by Analysts at Citigroup

Pfizer (NYSE:PFE – Get Free Report) had its price target lowered by investment analysts at Citigroup from $30.00 to $29.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. Citigroup’s price target would indicate a potential upside of 7.98% from the company’s […]

Leave a Reply

Your email address will not be published.

Previous post Prospect Financial Services LLC Acquires Shares of 1,255 Oracle Co. (NYSE:ORCL)
Next post Adobe Inc. (NASDAQ:ADBE) Shares Bought by Bay Rivers Group